Rounding up best medtech in 2015

January 6, 2016 | by

Medgadget’s 2015 roundup looks at nine innovative and in some cases life-saving medtech systems. These cover ground from diagnostics to robotic exoskeletons, from hearts to eyes and ears. Some are obviously early stage research projects, others are close to market. In eyewear news, a revamped Google Glass made the news with its FCC filing; we look at the Glass reboot and rival facial tech.

  • Evena Eyes-On ultrasound/infrared goggles that let the wearer visualize the peripheral and deeper vasculature for venipuncture procedures.
    • [grow_thumb image=”https://telecareaware.com/wp-content/uploads/2016/01/new-glass.jpg” thumb_width=”150″ /]And speaking of eyewear, Google Glass 2.0 made the end-of-year news with its leaked FCC filing detailing its changes in design, including a bigger screen, hardier build, improved camera and longer battery life. It also confirmed earlier rumors that Glass’ market was now medical and enterprise. Guardian, WSJ (video)
    • Other smart glasses from Vital Enterprises, Augmedix, Pristine.io, Aira.io and a beefed up Google Glass from ThirdEye for the ER recapped in MedCityNews.
  • A brain stent with pressure activated nanoparticles to break up vessel occlusions in the brain that cause ischemic strokes, developed by Harvard’s Wyss Institute and University of Massachusetts’ New England Center for Stroke Research.
  • A combination of EKSO Bionic‘s exoskeleton with UCLA‘s non-invasive spinal cord stimulation from NeuroRecovery Technologies which enabled paralyzed men to move their legs.
  • The XStat Rapid Hemostasis System, developed for the US military, now released for civilian use, which uses small sponges to stop bleeding.
  • Three pacemakers–one fetal, another powered by light and a third from EBR Systems’ WiSE technology that stimulates both sides of the heart
  • The PolyPhotonix Noctura 400 sleep mask for treating diabetic retinopathy
  • A two-part laser-based hearing aid from EarLens where one section is placed on the eardrum

Pitch@Palace 5.0 – a great opportunity for digital health entrepreneurs!

January 5, 2016 | by

pitchaTPALACE logoPitch@Palace 5.0 will be held at St James’s Palace on Monday 7th March 2016.

The preliminary Pitch@Palace Boot Camp will take place on Monday 22nd February, 2016 at the University of Cambridge. To participate in Pitch@Palace 5.0 you must be available to attend the Pitch@Palace Boot Camp.

Pitch@Palace Boot Camp will provide 42 entrepreneurs with the opportunity to hear from leading industry experts and Pitch@Palace alumni, as well as receiving support and mentoring. All participants are asked to prepare a three minute Pitch for a panel of judges, who will select between 12 to 15 entrepreneurs to pitch at St. James’s Palace on the 7th March.

All entrepreneurs attending Pitch@Palace Boot Camp will be invited to attend Pitch@Palace 5.0 and will have the opportunity to meet guests at the event.

Entry is open to entrepreneurs in the following categories: Agriculture, Food Sciences, Plant Sciences, Research Technologies, Diagnostics, Therapeutics, Medical Devices and Big Data and Healthcare. Businesses must be UK-based.

In addition to the mandatory Boot Camp, there are two optional ‘on tour’ events in London (26th January) and Manchester (2nd February).

Entries close 15th January – for more details, and to apply, click here.

The Duke of York founded Pitch@Palace – more background information is here.

Ten years on from the WSD: is the future brighter for telehealth? Can wind farms help?

January 4, 2016 | by

As Prof Mike Short pointed out recently, 2016 is the tenth anniversary of the start of the Whole System Demonstrator (WSD) programme that in retrospect, because of poor trial design, probably slowed the uptake of digital health in the UK more than any other single action. It seems appropriate therefore to look at how telehealth* has fared over that period, and perhaps even more importantly, is poised for the next ten years.

The mistakes of the WSD are well documented (eg here, here & here) – suffice it to say that it proved beyond all reasonable doubt, at least to this editor, that unlike medicine-based interventions, which seem less sensitive to their care pathway, digital health delivers most of its benefit through enabling a different, patient-centred care delivery, so every digital health intervention needs to be evaluated holistically, and in its own care pathway. Sadly over the ten years, much of the academic work looking at the benefits of telehealth has continued to evaluate the technology in the time-honoured way that medicines have been evaluated, with predictably largely equivocal results.

Those of us who have delivered telehealth projects though have a sense of disconnect as, time and again, a focused implementation – not a pilot – in which the staff delivering the service understand that it will be a permanent change for which they need radically to change the way they deliver care, yields huge returns on investments through savings typically in the 50-90% region. (more…)

A ‘top 50’ of 2016 US health tech, med tech conferences

December 30, 2015 | by

An unusually diverse list of conferences on health/medical technology and medical devices has been compiled by Pannam Imaging, which manufactures complex, mid-to-low volume integrated human-machine interfaces of use in several industries including healthcare technology. Many focus on medical devices, life sciences and biotech (BIO International in June) but some are on cybersecurity–and d.Health Summit (the d. is for disruptive) on 4 May in NYC is new to this Editor. Are all of them worth attending? Depends on your interest and market, but it’s not the usual suspects. Top MedTech Conferences: 50 Conferences on Health Tech, Medical Devices, and Medical Technology Worth Attending in 2016

Med-e-Tel Luxembourg

December 30, 2015 | by

6-8 April, Luxembourg

Presented by the International Society for Telemedicine & eHealth (ISfTeH), if your company is seeking international growth and/or exposure, Med-e-Tel since 2004 has reportedly attendees from over 100 countries focusing on the broad scope of health tech in the EU. There’s also still time to 8 January to submit a proposal on your experience or research in telemedicine, telehealth, eHealth and mHealth. For more information on abstract submission for speaking, see here. Information and registration in their latest newsletter here. TTA is a media partner of Med-e-Tel 2016.

Rounding up the funding rounds of 2015–and the deals some would like to see (?)

December 30, 2015 | by

Mobihealthnews rounded up 2015’s hot funding in the mobile health/health tech-related space, with helpful links to their articles. They cite as we have previously [TTA 16 Dec] Rock Health‘s flattish year-to-year 2015 total of $4.3 bn, but also StartUp Health’s bloom-off-rose 2015 digital health total of $5.8 bn–larger than Rock Health’s tote, but 17 percent off their 2014 total of $7 bn. If you consider the proportions: the top 10 deals raised $738 million–$130 million alone to the endlessly funded but yet to take over the world ZocDoc –the roster below $20m remains the longest, which is completely in accord with the lower part of Rock Health’s pyramid of angel-A-B rounds.

Yet Aditi Pai’s detailed summary strikes this Editor as useful in an unanticipated way. There is a certain sameness in the products and services of these companies, as if funders are seeking validation in similarity. ZocDoc, DoctoLib and Vitals–doctor profiles and appointment booking. Sharecare, Welltok, Novu, Noom, AbilTo, SocialWellth, Health Recovery Solutions, Jiff–health and wellness engagement programs/apps, many for corporate programs. Whoop, Sano, Sproutling, TuringSensor, Valencell, Moff and four others–wearables. Hello, Sleepace, Sproutling (baby)–sleep tracking. Klara, SkinVision, Spruce–dermatology apps. Beyond the gloomy forecast for unicorns (Theranos being the Child on the Milk Carton), how many of these corporate wellness programs, sleep trackers and wearables will be around in 2017? Mobihealthnews’ 2015 funding roundup.

MedCityNews takes a lighter-hearted (I think) look at 2016 deals. IBM would buy athenahealth mainly for its EHR and practice management data, plus data aggregator Validic, to beef up Watson; 23andMe, past its two years of troubles after stepping on FDA Superman’s cape, would buy PatientsLikeMe (endangering its community shaped credibility? 23PatientsLikeMe?) and the best–Theranos bought by Boston Heart Diagnostics/Eurofin (EU lab testing giant), which would reduce this unicorn to a pony…but one that might make it. Theranos also made VentureBeat’s list of Likely Carcasses in the Valley of Unicorn Death (to quote the article’s author). Chris Seper’s Deals He’d Like To See.

NIH funds in vivo CTE research with $16 million–$0 from NFL; “Concussion” released

December 23, 2015 | by

CTE research funded–and at a US theater near you Christmas Day

In the run-up to the holidays, our Readers may have missed another gift to those concerned with brain health–the National Institutes of Health (NIH) awarding of a major grant to fund research on chronic traumatic encephalopathy (CTE) to diagnose victims in vivo (while still alive). Awarded by NIH in conjunction with the National Institute of Neurological Disease and Stroke, the $16 million will go to researchers from Boston University, the Cleveland Clinic, Banner Alzheimer’s Institute (Arizona) and Brigham and Women’s Hospital in Boston. Leading the team is Robert Stern MD, Boston University professor and director of clinical research for BU’s Alzheimer’s disease and CTE centers, and a researcher we’ve followed since his June 2013 presentation at NYC’s German Center. According to a report in sports network ESPN’s ‘Outside the Lines’, the National Football League (NFL) refused to fund this research from their long term $30 million grant to the NIH due to Dr Stern’s alleged lack of objectivity; according to ESPN, a NIH official told ‘Outside the Lines’ that “the NFL’s $30 million gift was contingent on the league being able to veto decisions on projects that the money was funding.” Seemingly outside this research is another area of interest to Dr Stern–why some athletes have CTE, and others do not, as discussed in the May 2014 NYC MedTech ‘Brain Games’ presentation attended by this Editor.  Medical-Net (BU release), New York Times

Sports CTE and brain injury is back on the front pages with the release of the film ‘Concussion’, starring Will Smith as foundational researcher Bennet Omalu MD, the then-Pittsburgh forensic pathologist who uncovered CTE after performing a detailed brain examination of Pittsburgh Steelers center Mike Webster, who died of a heart attack aged 50 in 2002. His 2005 case report with others from University of Pittsburgh in Neurosurgery was the kick-off (so to speak) and so enraged the NFL that they attempted to have it withdrawn from the journal. In this interview with Medscape EIC Eric Topol MD, Dr Omalu discusses (more…)

Silicon Valley’s betting on ‘citizen doctors’, ‘citizen science’ and useful data

December 23, 2015 | by

A fascinating and slightly cynical overview of Silicon Valley’s ideological view of health tech that will fix our ‘deeply flawed healthcare system’ and what is getting funded (or not) is in next month’s San Francisco magazine. It profiles the ‘citizen doctor’ founders of vital signs ‘tricorder’ Scanadu (Sam–who’s not often mentioned–and Walter De Brouwer), bacteria tracker uBiome, ‘personal data recorder’ and experience charter We Are Curious (founded by Linda Avey, a long-departed co-founder of 23andme) and touches on the Theranos debacle. While these stories are bracing and in the instance of the De Brouwers, courageous, the notion of ‘citizen science’ (defined as direct-to-consumer health data) and its companion, Dr Eric Topol’s patient-centered/controlled medicine, has its drawbacks, viewed through the slightly gimlety ‘digital doctor’ eye of UC San Francisco’s Dr Robert Wachter. “The overarching message—not just from Theranos but from other companies struggling to get a toehold—is that, ultimately, the laws of economic gravity hold. The companies will have to produce products that add real value, either to patients or to payers. If they don’t, the market—or the regulators—won’t treat them kindly.” Flatly, there aren’t enough Quantified Selfers right now to support these companies. And Mr Market is a hard master. 23andme is back in the good graces of the FDA after a two-year scuffle and back doing direct response TV here in the US. Scanadu’s two products, Vitals (formerly Scout) and Urine are still not through the long slog of FDA clearance. The jury’s out on Theranos. And all these companies, including ‘unicorn’ Theranos, are bleeding cash and nowhere near turning a profit. ModernLuxury. Hat tip to Dr Topol via Twitter, who had a patient-centered conversation with Dr Wachter that we covered back in September.  Another recent podcast with Dr Wachter is here (Community Health Center radio).

Update: ‘Citizen science’ is nothing new, as revealed by the Science Museum (London)–it’s over 300 years old. While it entered the OED in 2014, ‘in 1715, Edmund Halley used Philosophical Transactions to ask colleagues to help him observe a total solar eclipse, prompting observers from all over the country to respond.’ Other examples are from Benjamin Robins in the same publication in 1749 on fireworks, Charles Darwin and evolution, to the present day. The difference is the flow–similar to what we now call crowdsourcing versus the individual using the data to affect their care.

 

Cornwall Council to terminate BT outsourcing deal

December 23, 2015 | by

The High Court has ruled that Cornwall Council is within its rights to terminate the multi-million pound [grow_thumb image=”https://telecareaware.com/wp-content/uploads/2015/12/Cornwall-Council.png” thumb_width=”150″ /]services outsourcing contract with BT because BT “did not provide … the service it had promised to the standard it had promised”.

Cornwall Council welcomed the High Court decision yesterday saying “The judge’s decision confirms the Council’s argument that BT Cornwall had been in material breach of the contract due to their failure to carry out services to the required contractual standards and, therefore, that we were justified in reaching the decision that we were entitled to terminate the contract.

“As a result of this decision, the Council intends to give notice of the contract before Christmas but there will be no immediate change in the arrangements as notice will not take effect until January.”

BT was awarded the 10-year contract in 2013 amid much controversy as was widely reported including here on TTA. (more…)

Federal Court denies TMB application to dismiss Teladoc case

December 22, 2015 | by

Readers may have read our article in April this year “Can State medical boards legally prevent telehealth activity?”. [grow_thumb image=”https://telecareaware.com/wp-content/uploads/2015/12/US-district-court-1.jpg” thumb_width=”150″ /]In that article we examined the potential impact of a case brought by the Federal Trade Commission against the North Carolina State Board of Dental Examiners. The case went all the way to the Supreme Court which determined that the State Board of Dental Examiners was not protected by immunity from anti-trust law.

Teladoc is now locked in a case with the Texas Medical Board (TMB) that is very similar to the North Carolina case and it too has gone along a similar path so far. In the latest development of this case, last week a Federal Court, the US District Court in Texas, denied the application by the TMB to dismiss a case brought by Teladoc that claims that the TMB broke anti-trust law.

What has brought Teladoc and the TMB to court in this way? (more…)

Are you a doctor interested in helping design healthy buildings?

December 21, 2015 | by

If so, there’s a professor at Reading University’s School of Construction Management and Engineering, Derek Clements-Croome, who want to meet you!

He firmly believes that those in building design need to work more with medics because they have valuable valid data about how the body and mind react in everyday environments. He is keen to learn about for example how heart rates, blood oxygenation, glucose levels and so on change when people stand and when they sit. This will help promote active working, based on real evidence that medics have. Building sickness syndrome and musculoskeletal conditions are highly relevant too. In 2013 in UK there were 131 million days off work; 60—90% of workers say they under-perform due to the poor physical environmental conditions. This costs about £100 billion per year. We could help to relieve pressure on doctors and NHS if we had healthier buildings (where we spend about 90% of our time)!

Apparently at the turn of the eighteenth century the French physician Xavier Bichat wrote a lot about the effects of poor air quality but after then the professions diverged.

Prof Croome is very keen to talk to any doctors interested and knowledgeable in these matters that would like to explore mutually beneficial collaboration. Email him at d.j.clements-croome@reading.ac.uk

Telegraph takes a quick look at CES 2016 trends, including wearables (updated)

December 19, 2015 | by
[grow_thumb image=”https://telecareaware.com/wp-content/uploads/2015/12/CES-GX-p25a2_400x400.jpg” thumb_width=”150″ /]It’s hard to believe that with the end of the year, the Next Big Event for many is the Consumer Technology’s Association‘s CES 2016 in Las Vegas 6-9 January. The Telegraph notes six trends in this breezy overview of what’s going to be The Next Big Things at the show: connected cars (lots of automaker concepts including the hush-hush Faraday electric), cybersecurity (especially irking this year with healthcare taking three of the top seven-Healthcare IT News), drones (buzzing at a location near you, despite the FAA), wearables (most impacting digital health), virtual/augmented reality (with utility in rehabilitation not mentioned here), and the ever-annoying, ever-cloying Internet of Things. On wearables, the show floor has apparently tripled in size since last year, and the article highlights the Mimo baby sleep monitor and the Qardio ECG monitor. (Unfortunately this Editor missed the November New York CES preview as she was attending HIMSS Connected Health, and due to other commitments won’t be going to Vegas, Baby.) Six predictions for CES 2016: drones, cybersecurity, wearables and more (Telegraph)

Update. During CES, Parks Associates will hosting their 7th annual CONNECTIONS Summit on 6-7  January (Wednesday – Thursday). The most health tech related session is ‘Wearables: Healthcare, IoT, and Smart Home Use Cases’ on Wednesday 10:30am-11:45am, with a panel including executives from Honeywell Life Care, Care Innovations, Qualcomm, Independa, IFTTT and Lumo Body Tech, hosted by director Harry Wang of Parks whom this Editor counts as a Grizzled Pioneer, Research Division. Separate registration required. Information and full agenda here.

To our Readers: Are you attending CES? Interested in contributing some insights? Contact Editor Donna.

47% of UK adults prefer virtual visits: Aviva Health Check study

December 19, 2015 | by | 1 Comment

Insurer Aviva’s latest Health Check study headlined the following findings about UK adults’ growing preference for digital health options, including a growth in acceptance of wearable monitors:

  • 47% are willing to be diagnosed digitally instead of face-to-face with their GP
  • 67% would use wearable technology to monitor long-term medical conditions such as diabetes or heart failure–especially those who are overweight (68%) or obese (71%)
  • The majority already using healthcare technology report improved health–63% of all age groups using a physical activity monitor say it has improved their health, rising to 66% of those with a heart rate monitor
  • Three in five (60%) non-users would use a physical activity or heart rate monitor in the future, while 52% would consider using a sleep pattern monitor
  • 55% agree the NHS should provide free technology to help people play an active role in improving their health
  • Younger age groups are most open (of course) to use of monitoring. 15% of those 25-34 use a physical activity monitor (compared to 8% overall) while 9% of 25-34s use a sleep pattern monitor (vs. 4% overall)

Aviva has an interest in digital health through its recently established customer partnership with babylon‘s UK-based telemedicine app [TTA 26 May]. The study was conducted by ICM Research for Aviva UK Health in August 2015. Respondents were invited from ICM’s online panel and 2,004 interviews were conducted amongst a nationally representative sample of the UK adult population.

The full study is available here to our Readers. Aviva release.

ReWalk powered exoskeleton now covered by the VA (US)

December 19, 2015 | by
[grow_thumb image=”https://telecareaware.com/wp-content/uploads/2015/12/rewalk.jpg” thumb_width=”200″ /]The advancement of robotic assistance in movement and walking took a sizable step forward (so to speak) with the Veterans Administration now covering the cost of and transition to the ReWalk powered exoskeleton on a national basis. It will be supplied to qualifying veterans with spinal cord injuries, but that qualification is a substantial hurdle in itself. According to the AP article, height and weight requirements are specific, and the paraplegic veteran has to be capable of wearing the supportive belt around the waist to keep the suit in place and carrying a backpack which holds the computer and rechargeable battery. Crutches still must be used for stability and the FDA as part of its clearance requires an assistant be nearby. It also cannot be worn for a full day, but even minimal use was proven to be beneficial; in VA pilot studies, the paraplegics who wore the ReWalk as little as four hours a week for three to five months experienced better bowel and bladder function, reduced back pain, improved sleep and less fatigue.

ReWalk has identified 45 paralyzed veterans who qualify, (more…)

2015 digital health VC funding flat, consolidations nearly double: Rock Health

December 16, 2015 | by

Rock Health published yesterday their 2015 annual Digital Health Funding report, and perhaps it is good news that 2015 activity maintained the blazing 2014 total at $4.3 bn. Still, it represents a compound annual growth (CAGR) from 2011-2015 of 30 percent.

Consumer digital health is thriving, with healthcare consumer engagement, personal health tools and tracking accounting for 23 percent of overall funding. Two of the six largest deals were won by consumer-driven genetic companies, 23andMe and Helix.

The one new record was that there were 278 deals across 248 companies, with an record-breaking average deal size of $15.6m. What continued is that the vast majority of funding deals (70 percent) were Series B and below, but C and C+ deals increased slightly.  It was also a big year for exits. M&A activity nearly doubled in volume with 180 deals and $6B in disclosed activity. Their index comprising shares of publicly traded digital health companies was off over 5 percent with two of this year’s IPOs trading lower than their opening prices.

According to the Rock Health newsletter, early-funded companies had a few zombies among them. Rock Health looked at companies up to five years ago, and found that 11 percent they classified as either dead or “zombies” (which have not raised a round in 3+ years). “Most likely to die? A disproportionate number of these zombie companies are in the care coordination, EHR, or clinical workflow space.”

The web page with a link to the full study is here. Unfortunately, the download is not free, but $99.